Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
|
Non-accelerated
filer
|
o
|
Smaller
reporting company
|
x
|
MATECH
CORP
|
||||||||
(Formerly
known as Material Technologies, Inc.)
|
||||||||
(A
Development Stage Company)
|
||||||||
December
31,
|
March
31,
|
|||||||
2008
|
2009
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 176,345 | $ | 219,810 | ||||
Accounts
receivable
|
41,961 | 97,977 | ||||||
Inventories
|
141,341 | 74,943 | ||||||
Prepaid
expenses and other current assets
|
359,227 | - | ||||||
Total
current assets
|
718,874 | 392,730 | ||||||
Property
and equipment, net
|
78,601 | 71,552 | ||||||
Loan
fee, net
|
- | 144,880 | ||||||
Intangible
assets, net
|
1,764 | 1,495 | ||||||
Deposit
|
2,348 | 2,348 | ||||||
$ | 801,587 | $ | 613,005 |
MATECH
CORP
|
||||||||
(Formerly
known as Material Technologies, Inc.)
|
||||||||
(A
Development Stage Company)
|
||||||||
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
||||||||
December
31,
|
March
31,
|
|||||||
2008
|
2009
|
|||||||
(Unaudited)
|
||||||||
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable and accrued expenses
|
$ | 670,207 | $ | 924,170 | ||||
Deferred
revenue - related party
|
90,000 | 50,000 | ||||||
Loans
payable - related party
|
- | 12,768 | ||||||
Current
portion of payable due on legal settlement
|
54,033 | 54,772 | ||||||
Current
portion of research and development sponsorship payable
|
25,000 | 25,000 | ||||||
Current
portion of Convertible debentures and
accrued interest payable, net of discount
|
1,859,325 | 2,301,803 | ||||||
Notes
payable
|
299,542 | 304,508 | ||||||
Total current liabilities | 2,998,107 | 3,673,021 | ||||||
Legal
settlement payable
|
155,978 | 143,254 | ||||||
Research
and development sponsorship payable, net of current
portion
|
778,549 | 787,956 | ||||||
Convertible
debentures and accrued interest payable, net of discount
|
335,834 | 562,767 | ||||||
Derivative
and warrant liabilities
|
210,497,575 | 329,442,548 | ||||||
211,767,936 | 330,936,525 | |||||||
Total liabilities | 214,766,043 | 334,609,546 | ||||||
Minority
interest in consolidated subsidiary
|
825 | 825 | ||||||
Commitments
and contingencies
|
||||||||
Stockholders'
deficit:
|
||||||||
Class
A preferred stock, $0.001 par value, liquidation
preference
|
||||||||
of $720
per share; 350,000 shares authorized; 337 shares issued
|
||||||||
and
outstanding as of December 31, 2008 and March 31,
2009
|
- | - | ||||||
Class
B preferred stock, $0.001 par value, liquidation preference
of
|
||||||||
$10,000
per share; 15 shares authorized; 0 shares issued
and
|
||||||||
outstanding
as of December 31, 2008 and March 31, 2009
|
- | - | ||||||
Class
C preferred stock, $0.001 par value, liquidation preference
of
|
||||||||
$0.001
per share; 25,000,000 shares authorized; 1,517 shares
issued
|
||||||||
and
outstanding as of December 31, 2008 and March 31, 2009
|
1 | 1 | ||||||
Class
D preferred stock, $0.001 par value, liquidation preference
of
|
||||||||
$0.001
per share; 20,000,000 shares authorized; 0 shares issued
|
||||||||
and
outstanding as of December 31, 2008 and March 31,
2009
|
- | - | ||||||
Class
E convertible preferred stock, $0.001 par value, no
liquidation
|
||||||||
preference;
60,000 shares authorized; 49,250 shares issued and
|
||||||||
outstanding
as of December 31, 2008 and March 31, 2009
|
49 | 49 | ||||||
Class
A Common Stock, $0.001 par value, 1,699,400,000 shares
|
||||||||
authorized;
99,408,963 shares issued and 24,389,794 shares
|
||||||||
outstanding
as of December 31, 2008; 107,416,290 shares
issued
|
||||||||
and
30,847,121 shares outstanding as of March 31, 2009
|
24,390 | 30,847 | ||||||
Class
B Common Stock, $0.001 par value, 600,000 shares
authorized,
|
||||||||
issued
and outstanding as of December 31, 2008 and March
31, 2009
|
600 | 600 | ||||||
Warrants
subscribed
|
10,000 | 10,000 | ||||||
Additional
paid-in-capital
|
367,125,759 | 368,287,619 | ||||||
Deficit
accumulated during the development stage
|
(581,117,806 | ) | (702,316,656 | ) | ||||
Treasury
stock ( 24,635 shares at cost at December 31,2008 and 25,448
shares at cost at March 31, 2009)
|
(8,274 | ) | (9,826 | ) | ||||
Total stockholders' deficit | (213,965,281 | ) | (333,997,366 | ) | ||||
$ | 801,587 | $ | 613,005 |
See notes to consolidated financial statements.
MATECH
CORP
|
||||||||||||
(Formerly
known as Material Technologies, Inc.)
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Three Months Ended
|
(Inception)
|
|||||||||||
March
31,
|
through
|
|||||||||||
2008
|
2009
|
March
31, 2009
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
Revenues:
|
||||||||||||
Research
and development
|
$ | - | $ | - | $ | 5,392,085 | ||||||
Revenue
from bridge testing
|
1,090 | 64,181 | 475,427 | |||||||||
Other
|
- | 90,000 | 374,125 | |||||||||
Total
revenues
|
1,090 | 154,181 | 6,241,637 | |||||||||
Costs
and expenses:
|
||||||||||||
Bridge
testing costs
|
- | 108,626 | 181,883 | |||||||||
Research
and development
|
158,993 | 84,566 | 21,175,388 | |||||||||
General
and administrative
|
20,328,325 | 1,046,075 | 332,124,032 | |||||||||
Modification
of research and development sponsorship agreement
|
- | - | 5,963,120 | |||||||||
Loss
on settlement of lawsuits
|
- | - | 1,267,244 | |||||||||
Total
costs and expenses
|
20,487,318 | 1,239,267 | 360,711,667 | |||||||||
Loss
from operations
|
(20,486,228 | ) | (1,085,086 | ) | (354,470,030 | ) | ||||||
Other
income (expense):
|
||||||||||||
Gain
(Loss) on modification of convertible debt
|
- | - | (378,485 | ) | ||||||||
Loss
on subscription receivable
|
- | (1,368,555 | ) | |||||||||
Interest
expense
|
(370,991 | ) | (1,166,188 | ) | (15,812,065 | ) | ||||||
Other-than-temporary
impairment of marketable securities available for
sale
|
- | - | (9,785,947 | ) | ||||||||
Loss
on shareholder settlement relating to failure to register common
shares
|
- | - | (39,407,195 | ) | ||||||||
Net
unrealized and realized loss of marketable securities
|
(8 | ) | (1,803 | ) | (9,400,021 | ) | ||||||
Change
in fair value of investments derivative liability
|
- | - | (210,953 | ) | ||||||||
Change
in fair value of derivative and warrant liabilities
|
8,559,576 | (118,944,973 | ) | (271,923,869 | ) | |||||||
Interest
income
|
12,443 | - | 483,056 | |||||||||
Other
|
- | - | (25,992 | ) | ||||||||
Other
income (expense), net
|
8,201,020 | (120,112,964 | ) | (347,830,026 | ) | |||||||
Loss
before provision for income taxes
|
(12,285,208 | ) | (121,198,050 | ) | (702,300,056 | ) | ||||||
Provision
for income taxes
|
(800 | ) | (800 | ) | (16,600 | ) | ||||||
Net
loss
|
$ | (12,286,008 | ) | $ | (121,198,850 | ) | $ | (702,316,656 | ) | |||
Per
share data:
|
||||||||||||
Basic
and diluted net loss per share
|
$ | (88.67 | ) | $ | (4.39 | ) | ||||||
Weighted
average Class A common shares outstanding - basic and
diluted
|
138,562 | 27,577,952 |
MATECH
CORP
|
||||||||||||
(Formerly
known as Material Technologies, Inc.)
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Three Months Ended
|
(Inception)
|
|||||||||||
March
31,
|
through
|
|||||||||||
2008
|
2009
|
March
31, 2009
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
loss
|
$ | (12,286,008 | ) | $ | (121,198,850 | ) | $ | (702,316,656 | ) | |||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||||
Gain
on modification of convertible debt
|
- | - | 378,485 | |||||||||
Impairment
loss
|
- | - | 21,391,528 | |||||||||
Loss
on charge off of subscription receivables
|
1,368,555 | |||||||||||
Stock
based compensation
|
4,580,400 | 568,317 | 211,046,698 | |||||||||
Increase
in debt for services and fees
|
- | 60,000 | 5,736,625 | |||||||||
Officer's
stock based compensation
|
15,000,000 | - | 86,460,675 | |||||||||
Issuance
of common stock for modification of
|
||||||||||||
research
and development sponsorship agreement
|
- | - | 7,738,400 | |||||||||
Issuance
of common stock in settlement for failure to
|
||||||||||||
register
common shares
|
- | - | 39,407,195 | |||||||||
Change
in fair value of derivative and warrant liabilities
|
- | 118,944,973 | 274,159,069 | |||||||||
Net
realized and unrealized loss on marketable securities
|
- | 1,803 | 7,897,508 | |||||||||
Other-than-temporary
impairment of marketable
|
||||||||||||
securities
available for sale
|
- | - | 9,785,946 | |||||||||
Legal
fees incurred for note payable
|
- | - | 1,456,142 | |||||||||
Accrued
interest expense added to principal
|
130,984 | 139,641 | 2,057,135 | |||||||||
Amortization
of discount on convertible debentures
|
339,725 | 934,142 | 13,457,173 | |||||||||
Change
in fair value of investments derivative liability
|
(8,559,576 | ) | - | 3,223,323 | ||||||||
Accrued
interest income added to principal
|
(2,407 | ) | - | (305,885 | ) | |||||||
Depreciation
and amortization
|
5,310 | 19,919 | 269,890 | |||||||||
Other
non-cash adjustments
|
- | - | (114,730 | ) | ||||||||
(Increase)
decrease in trade receivables
|
84,371 | (56,016 | ) | (148,304 | ) | |||||||
(Increase)
decrease in inventories
|
(14,790 | ) | 66,398 | (74,943 | ) | |||||||
(Increase)
decrease in prepaid expenses and other
|
- | |||||||||||
current
assets
|
32,500 | 109,935 | 423,779 | |||||||||
(Decrease)
increase in accounts payable and accrued
|
- | |||||||||||
expenses
|
(161,759 | ) | 241,977 | 2,781,472 | ||||||||
(Decrease)
Increase in deferred revenue - related party
|
- | (40,000 | ) | 50,000 | ||||||||
Net
cash used in operating activities
|
(851,250 | ) | (207,761 | ) | (13,870,920 | ) | ||||||
Cash
flows from investing activities:
|
||||||||||||
Proceeds
from the sale of marketable securities
|
300,000 | - | 3,758,476 | |||||||||
Purchase
of marketable securities
|
- | - | (2,206,379 | ) | ||||||||
Investment
in certificate of deposits and commercial paper
|
(565,000 | ) | - | (1,965,000 | ) | |||||||
Redemptions
of certificate of deposits and commercial paper
|
858,922 | - | 1,965,000 | |||||||||
Payment
received on officer loans
|
- | - | 876,255 | |||||||||
Funds
advanced to officers
|
- | - | (549,379 | ) | ||||||||
Proceeds
received in acquisition of consolidated subsidiaries
|
- | - | 600,000 | |||||||||
Purchase
of property and equipment
|
(17,167 | ) | (12,600 | ) | (386,020 | ) | ||||||
Investment
in joint ventures
|
- | - | (102,069 | ) | ||||||||
Proceeds
from foreclosure
|
- | - | 44,450 | |||||||||
Proceeds
from the sale of property and equipment
|
- | - | 19,250 | |||||||||
Payment
for license agreement
|
- | - | (6,250 | ) | ||||||||
Net
cash provided by (used in ) investing activities
|
576,755 | (12,600 | ) | 2,048,334 |
MATECH
CORP
|
||||||||||||
(Formerly
known as Material Technologies, Inc.)
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
||||||||||||
From
October 21, 1983
|
||||||||||||
For
the Three Months Ended
|
(Inception)
|
|||||||||||
March
31,
|
through
|
|||||||||||
2008
|
2009
|
March
31, 2009
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
Cash
flow from financing activities:
|
||||||||||||
Proceeds
from the sale of common stock and warrants
|
$ | - | $ | 671 | $ | 9,465,248 | ||||||
Proceeds
from convertible debentures and other
|
||||||||||||
notes
payable
|
- | 295,000 | 3,647,766 | |||||||||
Proceeds
from the sale of preferred stock
|
- | - | 473,005 | |||||||||
Fees
incurred in debt financing
|
- | - | (1,505,932 | ) | ||||||||
Capital
contributions
|
- | - | 301,068 | |||||||||
Purchase
of treasury stock
|
(1,590 | ) | (4,025 | ) | (180,939 | ) | ||||||
Principal
reduction on notes payable
|
(252 | ) | (27,820 | ) | (152,820 | ) | ||||||
Payment
on proposed reorganization
|
- | - | (5,000 | ) | ||||||||
Net
cash provided by (used in) financing activities
|
(1,842 | ) | 263,826 | 12,042,396 | ||||||||
Net
change in cash and cash equivalents
|
(276,337 | ) | 43,465 | 219,810 | ||||||||
Cash
and cash equivalents, beginning of period
|
809,710 | 176,345 | - | |||||||||
Cash
and cash equivalents, end of period
|
$ | 533,373 | $ | 219,810 | $ | 219,810 | ||||||
Supplemental
disclosure of cash flow information:
|
||||||||||||
Interest
paid during the period
|
$ | 281 | $ | - | ||||||||
Income
taxes paid during the period
|
$ | 800 | $ | - |
Supplemental
disclosures of non-cash investing and financing
activities:
|
||||||||
2009
|
||||||||
In
January 2009, the Company issued its President 274,000 shares of its
common stock in a cashless
|
||||||||
exercise
of 274,347 options.
|
||||||||
In
February 2009, the Company issued 6,000,000 shares of its common stock in
a conversion of
|
||||||||
$600,000
of convertible debt.
|
||||||||
2008
|
||||||||
During
the three months ended March 31, 2008, the Company issued 4,229 shares of
its Class A common stock in
|
||||||||
the
conversion of $491,132 of convertible debt.
|
||||||||
During
the three months ended March 31, 2008, the Company issued 8,208 shares of
its Class A common stock
|
||||||||
for
consulting services valued at $3,580,400.
|
||||||||
During
the three months ended March 31, 2008, the Company issued 378 shares of
its Class A common stock
|
||||||||
pursuant
to the anti-dilution provisions of a settlement agreement.
|
||||||||
During
the three months ended March 31, 2008. a former employee returned 450
shares of the Company's Class A
|
||||||||
common
stock to treasury which were subsequently cancelled.
|
||||||||
During
the three months ended March 31, 2008, the Company issued 34,500 shares of
its Class A common stock
|
||||||||
in
consideration of the exercise of cashless warrants. The Company accrued
derivative liability in connection with the
|
||||||||
granting
of the warrants, which had a balance of $1,151,900 on the date of
exercise. The liability balance was credited o equity.
|
||||||||
During
the three months ended March 31, 2008, the Company's contingent obligation
to Mr. Beck under a settlement agreement
|
||||||||
was
reduced to $0, therefore the Company reduced its legal settlement
liability by the remaining accrued provision of
$230,000,
|
||||||||
which
was credited to equity.
|
Trade
receivables
|
$ | 97,977 |
Finished
goods
|
$ | 74,943 |
Office
and computer equipment
|
$ | 27,645 | ||
Manufacturing
equipment
|
243,121 | |||
270,766 | ||||
Less
accumulated depreciation
|
(199,214 | ) | ||
$ | 71,552 |
Period
of
Amortization
|
|||||
Patent
costs
|
17
years
|
$ | 28,494 | ||
License
agreement (see Note 7)
|
17
years
|
6,250 | |||
Website
|
5
years
|
5,200 | |||
39,944 | |||||
Less
accumulated amortization
|
(38,449 | ) | |||
$ | 1,495 |
2009
|
$ | 1,076 | ||
2010
|
$ | 419 |
August
2, 2009
|
$ | 30,000 | ||
August
2, 2010
|
$ | 30,000 | ||
August
2, 2011 and each year thereafter
|
$ | 50,000 |
January
29, 2010
|
$ | 21,000 | ||
January
29, 2011
|
$ | 32,000 | ||
January
29, 2012
|
$ | 42,000 |
January
1, 2009
|
$ | 10,000 | ||
January
1, 2010
|
$ | 20,000 | ||
January
1, 2011 and each year thereafter
|
$ | 30,000 |
·
|
If
an Event of Default occurs under the Notes, and, if such Event of Default
is curable, such Event of Default continues for a period of 30 days
without being cured, then the 10% interest rate set forth in the Notes
will be increased to a Default Interest Rate of 18% per annum, and the
total balance of principal and accrued interest of the debentures shall
bear interest at the Default Interest Rate from the date of the occurrence
of such Event of Default.
|
·
|
In
addition, the entry of any judgment against the Company in excess of
$150,000, regardless of where, how, to whom or under what agreement such
liability arises, shall be an Event of Default under the Debentures,
unless (i) the Company pays such judgment within 60 days, or (ii) the
Company duly files an appeal of such judgment and execution of such
judgment is stayed. Finally, the entry of any order or judgment
in favor of any judgment
creditor or other creditor attaching the assets of the Company shall be an
Event of Default under these debentures. The conversion price
of the debentures shall not be at any time more than $0.10 per share,
regardless of any combination of shares of the Common Stock of the Company
by reverse split or
otherwise.
|
·
|
If
an Event of Default occurs which is not cured within its applicable cure
period, if it is curable, the conversion price of these debentures after
such cure period has expired shall be reduced to half of the pre-Event of
Default conversion price. For clarification, if the conversion
price before an Event of Default were the lesser of 50% of market price or
$0.10, then the new conversion price would be the lesser of 25% of market
price or $0.05.
|
·
|
The
Company shall not issue any shares of its Class A Common Stock without a
legend stating that such shares may not be sold, transferred, pledged,
assigned or alienated for a period of at least one year following the date
of the issuance of such certificate, other than shares issued to or with
the written consent of the Holder. Notwithstanding the
foregoing, this provision shall not apply to (i) any shares issued to
purchasers in a financing where the Company receives net proceeds of at
least Five Hundred Thousand Dollars ($500,000) and the shares are sold for
not less than fifty percent (50%) of the closing price of the Company’s
common stock reported as of the closing date of such financing, and (ii)
any shares issued in connection with an acquisition of assets by the
Company where (a) the Company provides to the Holder a fairness opinion as
to the value of the acquired assets, and (b) the Company receives assets
that are worth at least fifty percent (50%) of the closing price per share
of the Company’s common stock as of the closing date of the
acquisition.
|
·
|
The
Company shall not enter into any agreement pursuant to which any party
other than the Holder has pre-emptive rights, the right to receive shares
of any class of securities of the Company for no additional consideration,
the right to receive a set, pre-determined percentage of the outstanding
shares of the Company for any period of time, or any other similar right
that has the effect of maintaining a set percentage of the issued and/or
outstanding shares of any class or classes of the capital stock of the
Company.
|
·
|
The
Company shall not enter into any agreement giving another party
anti-dilution protection unless (1) all shares received pursuant to such
provision are subject to a two-year lock-up from the date of issuance, and
(2) all such shares received are subject to a “dribble-out,” following the
two-year lock-up, restricting their sale to not more than 1/20th
of 5% of the previous month’s total trading volume in any single trading
day.
|
·
|
The Company will not
file any Registration Statement on Form S-8 nor issue any shares
registered on Form S-8, exclusive of shares currently registered on Form
S-8. However, when the total capital in the Company’s cash
account drops below $500,000, the Company may issue up to $30,000 worth of
securities registered on Form S-8, valued at
|
·
|
the
market price of the common stock on the date of issuance, per month,
non-cumulative. Any issuance of S-8 shares will be supported by
an opinion of the Company’s counsel that such issuance complies in all
respects with federal securities laws. This opinion will be
provided to the legal representative of the Holder upon
request. Further, the Company will ensure that every entity or
individual that receives S-8 shares will be subject to a “dribble-out”
restricting their sale to not more than 1/20th
of 2% of the previous month’s total trading volume in any single trading
day, non-cumulative. The above described dribble-out is not an
aggregate sale restriction for all entities and individuals receiving S-8
shares.
|
·
|
The
Company acknowledges that the conversion price of the Debenture shall not
be effected by any such reverse split, and that after giving effect to
such reverse split, the conversion price shall remain the lesser of (i)
50% of the averaged ten closing prices for the Company’s Common Stock for
the ten trading days immediately preceding the Conversion Date or (ii)
$0.10. The Holder consents to this action. The
parties acknowledge that the Company is not obligated to complete this
reverse-split, or any reverse
split.
|
·
|
The
shareholder lockup provisions will not apply to up to any shares held by
Mr. Robert Bernstein, and sold by him personally in a bona-fide sale to an
unrelated, unaffiliated third party; provided, that (i) the number of
shares sold shall not exceed Two Million Five Hundred Thousand Dollars
($2,500,000) worth of stock, calculated based on the number of shares sold
multiplied by the closing price of the stock on the date such shares are
sold (if a market trade) or transferred on the books of the transfer agent
(if a private transfer). Once Two Million Five Hundred Thousand
Dollars ($2,500,000) worth of stock has been sold as calculated above, the
lockup on whatever remains of the shares owned by Mr. Bernstein (if
any) goes back into effect. In this regard, if Mr. Bernstein
sells any of his shares without legend, then he may only sell up to 1/20th
of 5% of the previous month’s total trading volume in any single trading
day, and he may not sell more than 1% of the issued and outstanding shares
of Matech during any 90 day period. Further, if Mr. Bernstein sells
any of his shares, he must have such shares transferred on the books of
the transfer agent within five business days of the sale. Mr.
Bernstein shall comply with all reporting requirements under Section 16 of
the Securities Exchange Act of 1934, as
amended.
|
Fatigue Fuse
|
EFS
|
||
University
of Pennsylvania (see Note 7)
|
|
|
|
Net
sales of licensed products
|
-
|
7.00%
|
|
Net
sales of services
|
-
|
2.50%
|
|
Shareholder
|
1.00%
|
0.50%
|
2010
|
$ | 54,772 | ||
2011
|
52,842 | |||
2012
|
56,101 | |||
2013
|
34,311 | |||
$ | 198,026 |